Literature DB >> 26778191

Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma.

Jia Liu1, Yu Mao2, Zhenjiang Li3, Dakai Zhang1, Zicheng Zhang4, Shengnan Hao5, Baosheng Li4.   

Abstract

PURPOSE: To explore the clinical potential of texture analysis using contrast-enhanced 3.0T magnetic resonance imaging (MRI) for predicting the therapeutic response of nasopharyngeal carcinoma (NPC) to chemoradiotherapy.
MATERIALS AND METHODS: The dataset comprised pretreatment T1 -, T2 -, and diffusion-weighted MR images from 53 eligible patients with newly diagnosed NPC. The patients were divided into two sets: the training set including 31 responders and 11 nonresponders and the testing set including eight responders and three nonresponders. The region of interest (ROI) was delineated by two radiologists for each sequence. Quantitative image parameters were extracted and statistically filtered to identify a subset of reproducible and nonredundant parameters that were used to construct the predictive model. The internal validation was performed using stratified 10-fold cross-validation in the training set and the external validation was performed in the testing set. McNemar's test was used to test the statistical difference between the performances of the extracted parameters in predicting the treatment response.
RESULTS: All three parameter sets showed potential in predicting treatment response with high accuracy (T1 : 0.952/0.939, T2 : 0.904/0.905, diffusion-weighted [DWI]: 0.881/0.929). Supervised learning models based on parameters extracted from the T1 sequence showed better classification performance than those extracted from the T2 -weighted (T2 W) (artificial neural network [ANN]: P = 0.043, k-nearest neighbors [kNN]: P = 0.033) and DWI (ANN: P = 0.032. kNN: P = 0.014). No statistical difference was observed in the performance of the two classifiers (P = 0.083).
CONCLUSION: Texture analysis based on T1 W, T2 W, and DWI could act as imaging biomarkers of tumor response to chemoradiotherapy in NPC patients and serve as a new radiological analysis tool for treatment prediction. J. Magn. Reson. Imaging 2016;44:445-455.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  magnetic resonance imaging; nasopharyngeal carcinoma; texture analysis; treatment effect prediction

Mesh:

Substances:

Year:  2016        PMID: 26778191     DOI: 10.1002/jmri.25156

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  36 in total

1.  MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.

Authors:  Lina Zhao; Jie Gong; Yibin Xi; Man Xu; Chen Li; Xiaowei Kang; Yutian Yin; Wei Qin; Hong Yin; Mei Shi
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

Review 2.  Texture analysis of medical images for radiotherapy applications.

Authors:  Elisa Scalco; Giovanna Rizzo
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

Review 3.  Pattern recognition for predictive, preventive, and personalized medicine in cancer.

Authors:  Tingting Cheng; Xianquan Zhan
Journal:  EPMA J       Date:  2017-03-09       Impact factor: 6.543

4.  Spectral multi-energy CT texture analysis with machine learning for tissue classification: an investigation using classification of benign parotid tumours as a testing paradigm.

Authors:  Eiman Al Ajmi; Behzad Forghani; Caroline Reinhold; Maryam Bayat; Reza Forghani
Journal:  Eur Radiol       Date:  2018-01-02       Impact factor: 5.315

5.  MRI-Based Texture Analysis to Differentiate Sinonasal Squamous Cell Carcinoma from Inverted Papilloma.

Authors:  S Ramkumar; S Ranjbar; S Ning; D Lal; C M Zwart; C P Wood; S M Weindling; T Wu; J R Mitchell; J Li; J M Hoxworth
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-02       Impact factor: 3.825

6.  MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.

Authors:  Haimei Chen; Xiao Zhang; Xiaohong Wang; Xianyue Quan; Yu Deng; Ming Lu; Qingzhu Wei; Qiang Ye; Quan Zhou; Zhiming Xiang; Changhong Liang; Wei Yang; Yinghua Zhao
Journal:  Eur Radiol       Date:  2021-03-30       Impact factor: 5.315

7.  Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups.

Authors:  En-Hong Zhuo; Wei-Jing Zhang; Hao-Jiang Li; Guo-Yi Zhang; Bing-Zhong Jing; Jian Zhou; Chun-Yan Cui; Ming-Yuan Chen; Ying Sun; Li-Zhi Liu; Hong-Min Cai
Journal:  Eur Radiol       Date:  2019-03-14       Impact factor: 5.315

8.  Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features.

Authors:  Ping Yin; Ning Mao; Chao Zhao; Jiangfen Wu; Chao Sun; Lei Chen; Nan Hong
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

9.  MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors.

Authors:  Ankush Bhatia; Maxwell Birger; Harini Veeraraghavan; Hyemin Um; Florent Tixier; Anna Sophia McKenney; Marina Cugliari; Annalise Caviasco; Angelica Bialczak; Rachna Malani; Jessica Flynn; Zhigang Zhang; T Jonathan Yang; Bianca D Santomasso; Alexander N Shoushtari; Robert J Young
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

10.  Radiomic analysis for response assessment in advanced head and neck cancers, a distant dream or an inevitable reality? A systematic review of the current level of evidence.

Authors:  Amrita Guha; Steve Connor; Mustafa Anjari; Harish Naik; Musib Siddiqui; Gary Cook; Vicky Goh
Journal:  Br J Radiol       Date:  2019-11-06       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.